• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证 2 型糖尿病患者全因死亡率预测模型。

Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.

机构信息

Unit of Endocrinology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

出版信息

Diabetes Care. 2013 Sep;36(9):2830-5. doi: 10.2337/dc12-1906. Epub 2013 May 1.

DOI:10.2337/dc12-1906
PMID:23637348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3747924/
Abstract

OBJECTIVE

To develop and validate a parsimonious model for predicting short-term all-cause mortality in patients with type 2 diabetes mellitus (T2DM).

RESEARCH DESIGN AND METHODS

Two cohorts of patients with T2DM were investigated. The Gargano Mortality Study (GMS, n = 679 patients) was the training set and the Foggia Mortality Study (FMS, n = 936 patients) represented the validation sample. GMS and FMS cohorts were prospectively followed up for 7.40 ± 2.15 and 4.51 ± 1.69 years, respectively, and all-cause mortality was registered. A new forward variable selection within a multivariate Cox regression was implemented. Starting from the empty model, each step selected the predictor that, once included into the multivariate Cox model, yielded the maximum continuous net reclassification improvement (cNRI). The selection procedure stopped when no further statistically significant cNRI increase was detected.

RESULTS

Nine variables (age, BMI, diastolic blood pressure, LDL cholesterol, triglycerides, HDL cholesterol, urine albumin-to-creatinine ratio, and antihypertensive and insulin therapy) were included in the final predictive model with a C statistic of 0.88 (95% CI 0.82-0.94) in the GMS and 0.82 (0.76-0.87) in the FMS. Finally, we used a recursive partition and amalgamation algorithm to identify patients at intermediate and high mortality risk (hazard ratio 7.0 and 24.4, respectively, as compared with those at low risk). A web-based risk calculator was also developed.

CONCLUSIONS

We developed and validated a parsimonious all-cause mortality equation in T2DM, providing also a user-friendly web-based risk calculator. Our model may help prioritize the use of available resources for targeting aggressive preventive and treatment strategies in a subset of very high-risk individuals.

摘要

目的

建立并验证一个用于预测 2 型糖尿病(T2DM)患者短期全因死亡率的简约模型。

研究设计与方法

研究纳入了两批 T2DM 患者。Gargano 死亡率研究(GMS,n=679 例患者)为训练集,Foggia 死亡率研究(FMS,n=936 例患者)为验证样本。GMS 和 FMS 队列分别前瞻性随访了 7.40±2.15 年和 4.51±1.69 年,记录全因死亡率。在多变量 Cox 回归中,实施了一种新的向前变量选择方法。从空模型开始,每一步选择的预测因子是,一旦包含在多变量 Cox 模型中,就会产生最大的连续净重新分类改善(cNRI)。当没有进一步检测到统计学上显著的 cNRI 增加时,选择过程停止。

结果

最终预测模型纳入了 9 个变量(年龄、BMI、舒张压、LDL 胆固醇、三酰甘油、HDL 胆固醇、尿白蛋白/肌酐比值、以及降压和胰岛素治疗),在 GMS 中的 C 统计量为 0.88(95%CI 0.82-0.94),在 FMS 中为 0.82(0.76-0.87)。最后,我们使用递归分区和合并算法来识别处于中危和高危死亡率的患者(与低危患者相比,风险比分别为 7.0 和 24.4)。还开发了一个基于网络的风险计算器。

结论

我们建立并验证了一个用于预测 T2DM 患者全因死亡率的简约方程,并提供了一个易于使用的基于网络的风险计算器。我们的模型可以帮助优先使用现有资源,针对具有极高风险的个体亚组实施积极的预防和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e947/3747924/c91baa5e0065/2830fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e947/3747924/c91baa5e0065/2830fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e947/3747924/c91baa5e0065/2830fig1.jpg

相似文献

1
Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.开发和验证 2 型糖尿病患者全因死亡率预测模型。
Diabetes Care. 2013 Sep;36(9):2830-5. doi: 10.2337/dc12-1906. Epub 2013 May 1.
2
Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.2 型糖尿病患者死亡率风险估计(ENFORCE):一个廉价且简约的预测模型。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215.
3
On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.2型糖尿病患者血清尿酸水平与全因死亡率之间的非线性关联
Atherosclerosis. 2017 May;260:20-26. doi: 10.1016/j.atherosclerosis.2017.03.008. Epub 2017 Mar 9.
4
Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.波兰成年人群的全球心血管疾病死亡风险:在多中心全国性WOBASZ和WOBASZ老年研究中对队列的前瞻性评估。
Kardiol Pol. 2016;74(3):262-73. doi: 10.5603/KP.a2015.0175. Epub 2015 Sep 14.
5
Which creatinine-based estimated glomerular filtration rate equation best predicts all-cause mortality in Chinese subjects with type 2 diabetes?哪种基于肌酐的估计肾小球滤过率方程能最好地预测中国2型糖尿病患者的全因死亡率?
Diabetes Res Clin Pract. 2017 Apr;126:25-29. doi: 10.1016/j.diabres.2017.01.010. Epub 2017 Jan 29.
6
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.基于人群的回顾性队列研究:为中国 2 型糖尿病患者开发心血管疾病风险预测模型和工具。
Diabetes Obes Metab. 2018 Feb;20(2):309-318. doi: 10.1111/dom.13066. Epub 2017 Aug 25.
7
Establishment of Clinical Prediction Model Based on the Study of Risk Factors of Stroke in Patients With Type 2 Diabetes Mellitus.基于 2 型糖尿病患者中风危险因素研究的临床预测模型的建立。
Front Endocrinol (Lausanne). 2020 Aug 25;11:559. doi: 10.3389/fendo.2020.00559. eCollection 2020.
8
Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.2 型糖尿病患者致动脉粥样硬化性血脂异常与全因死亡率的独立相关性及性别对其的影响:一项前瞻性队列研究。
Cardiovasc Diabetol. 2021 Jan 30;20(1):28. doi: 10.1186/s12933-021-01224-7.
9
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].[非酒精性脂肪性肝病增加2型糖尿病发病率:一项基于苏南某乡镇老年人群的队列研究]
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223.
10
Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).中肾肽前体片段、新发白蛋白尿与 2 型糖尿病患者的心血管和全因死亡率(ZODIAC-30)
Diabetes Care. 2014;37(3):839-45. doi: 10.2337/dc13-1852. Epub 2013 Oct 29.

引用本文的文献

1
A scoring model integrating CXCL9, GDF15, FGF21, and NfL, predicts long-term mortality in type 2 diabetes: a retrospective study.整合CXCL9、GDF15、FGF21和NfL的评分模型预测2型糖尿病的长期死亡率:一项回顾性研究
Cardiovasc Diabetol. 2025 Jul 8;24(1):270. doi: 10.1186/s12933-025-02830-5.
2
Inflammation and Prediction of Death in Type 2 Diabetes. Evidence of an Intertwined Link With Tryptophan Metabolism.2型糖尿病中的炎症与死亡预测:与色氨酸代谢存在交织联系的证据
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1323-e1333. doi: 10.1210/clinem/dgae593.
3
Development and validation of a nomogram of all-cause mortality in adult Americans with diabetes.

本文引用的文献

1
Association of weight status with mortality in adults with incident diabetes.体重状况与新发糖尿病成人死亡率的相关性。
JAMA. 2012 Aug 8;308(6):581-90. doi: 10.1001/jama.2012.9282.
2
Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.在英国预测心血管疾病 10 年风险:QRISK2 新版本的独立和外部验证。
BMJ. 2012 Jun 21;344:e4181. doi: 10.1136/bmj.e4181.
3
Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD).
开发并验证了一个针对美国成年糖尿病患者全因死亡率的列线图。
Sci Rep. 2024 Aug 19;14(1):19148. doi: 10.1038/s41598-024-69581-3.
4
Developing a prediction model for all-cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China.建立中国上海 2 型糖尿病患者全因死亡率风险预测模型。
J Diabetes. 2023 Jan;15(1):27-35. doi: 10.1111/1753-0407.13343. Epub 2022 Dec 16.
5
Precision prognostics for the development of complications in diabetes.糖尿病并发症发展的精准预测。
Diabetologia. 2022 Nov;65(11):1867-1882. doi: 10.1007/s00125-022-05731-4. Epub 2022 Jun 21.
6
Developing a Prediction Model for 7-Year and 10-Year All-Cause Mortality Risk in Type 2 Diabetes Using a Hospital-Based Prospective Cohort Study.利用一项基于医院的前瞻性队列研究开发2型糖尿病患者7年和10年全因死亡风险预测模型。
J Clin Med. 2021 Oct 18;10(20):4779. doi: 10.3390/jcm10204779.
7
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation.新冠肺炎时期的内分泌学:重塑糖尿病服务和新兴创新。
Eur J Endocrinol. 2020 Aug;183(2):G67-G77. doi: 10.1530/EJE-20-0377.
8
Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach.运用机器学习方法预测行或不行代谢手术后 2 型糖尿病终末器官并发症的 10 年风险。
Diabetes Care. 2020 Apr;43(4):852-859. doi: 10.2337/dc19-2057. Epub 2020 Feb 6.
9
Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.2 型糖尿病患者死亡率风险估计(ENFORCE):一个廉价且简约的预测模型。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215.
10
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.EXSCEL 试验:根据 2 型糖尿病患者的基线风险,每周一次艾塞那肽对临床结局的影响。
J Am Heart Assoc. 2018 Oct 2;7(19):e009304. doi: 10.1161/JAHA.118.009304.
2 型糖尿病患者 8 年死亡率的预测因素:糖尿病转化研究行动(TRIAD)。
Diabetes Care. 2012 Jun;35(6):1301-9. doi: 10.2337/dc11-2281. Epub 2012 Mar 19.
4
Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.用于评估判别改善的新指标:适用于正态变量和嵌套模型的净重新分类和综合判别改善。
Stat Med. 2012 Jan 30;31(2):101-13. doi: 10.1002/sim.4348. Epub 2011 Dec 7.
5
Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients.肥胖、血清脂蛋白和载脂蛋白 E 基因型对住院老年患者死亡率的影响。
Rejuvenation Res. 2011 Apr;14(2):111-8. doi: 10.1089/rej.2010.1058.
6
Diabetes mellitus, fasting glucose, and risk of cause-specific death.糖尿病、空腹血糖与特定病因死亡风险。
N Engl J Med. 2011 Mar 3;364(9):829-841. doi: 10.1056/NEJMoa1008862.
7
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.将净重新分类改进计算扩展到测量新生物标志物的有用性。
Stat Med. 2011 Jan 15;30(1):11-21. doi: 10.1002/sim.4085. Epub 2010 Nov 5.
8
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial.退伍军人事务糖尿病试验中的血压和心血管疾病风险。
Diabetes Care. 2011 Jan;34(1):34-8. doi: 10.2337/dc10-1420. Epub 2010 Nov 8.
9
A risk score to predict bleeding in patients with acute coronary syndromes.用于预测急性冠脉综合征患者出血风险的评分。
J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076.
10
Reclassification calculations for persons with incomplete follow-up.对随访不完整者的重新分类计算。
Ann Intern Med. 2010 Feb 2;152(3):195-6; author reply 196-7. doi: 10.7326/0003-4819-152-3-201002020-00019.